Literature DB >> 9192935

Vital capacities in acute and chronic airway obstruction: dependence on flow and volume histories.

V Brusasco1, R Pellegrino, J R Rodarte.   

Abstract

The aim of this study was to investigate whether measurements of vital capacity (VC) are affected by the direction of the manoeuvre (inspiratory vs expiratory) and by the rate of expiratory flow. The study was performed on 25 individuals with chronic airway obstruction (CAO) and a forced expiratory volume in one second (FEV1) (expressed in standardized residuals (SR)) of -2.0+/-1.4 SD (CAO group), and 10 asthmatic subjects with methacholine (MCh)-induced bronchoconstriction (FEV1 -23+/-1.02 SR) (MCh group). VCs were measured during fast inspiration following both slow (FIVCse) and forced (FIVCfe) expiration from end-tidal inspiration to residual volume (RV), and during slow (EVC) or forced (FVC) expiration from total lung capacity (TLC). In the CAO group, FVC was the smallest volume (3.75+/-1.03 L) and significantly different from the other three estimates of VC; FIVCse (4.03+/-0.91 L) was the largest volume and significantly different from FVC and FIVCfe (3.83+/-0.98 L). In the MCh group, FVC (4.16+/-0.94 L) and EVC (4.19+/-0.89 L) were the largest volumes, although only the difference between FVC and FIVCfe (3.76+/-0.81 L) reached statistical significance. These data suggest that both flow and volume histories contribute to decreased vital capacities during bronchoconstriction. However, whereas increasing expiratory flow always tends to decrease vital capacity, the volume history of full inflation has different effects in chronic and acute bronchoconstriction, probably due to different effects on airway calibre. These results stress the importance of using standardized manoeuvres in order to obtain comparable values of vital capacity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9192935     DOI: 10.1183/09031936.97.10061316

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  14 in total

1.  ARTP statement on pulmonary function testing 2020.

Authors:  Karl Peter Sylvester; Nigel Clayton; Ian Cliff; Michael Hepple; Adrian Kendrick; Jane Kirkby; Martin Miller; Alan Moore; Gerrard Francis Rafferty; Liam O'Reilly; Joanna Shakespeare; Laurie Smith; Trefor Watts; Martyn Bucknall; Keith Butterfield
Journal:  BMJ Open Respir Res       Date:  2020-07

Review 2.  Spirometric indices of early airflow impairment in individuals at risk of developing COPD: Spirometry beyond FEV1/FVC.

Authors:  Daniel Hoesterey; Nilakash Das; Wim Janssens; Russell G Buhr; Fernando J Martinez; Christopher B Cooper; Donald P Tashkin; Igor Barjaktarevic
Journal:  Respir Med       Date:  2019-08-09       Impact factor: 3.415

3.  Postoperative pulmonary function changes according to the resected lobe: a 1-year follow-up study of lobectomized patients.

Authors:  Masanori Yokoba; Tsuyoshi Ichikawa; Shinya Harada; Masahito Naito; Yukitoshi Sato; Masato Katagiri
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

4.  Difference Between Slow and Forced Vital Capacity and Its Relationship with Dynamic Hyperinflation in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Larissa Martinez; Diego Rodrigues; Leila Donária; Karina C Furlanetto; Felipe Vilaça Cavallari Machado; Lorena Paltanin Schneider; Marcos Ribeiro; Nidia A Hernandes; Fabio Pitta
Journal:  Lung       Date:  2018-10-29       Impact factor: 2.584

5.  Increased difference between slow and forced vital capacity is associated with reduced exercise tolerance in COPD patients.

Authors:  Wei Yuan; Xin He; Qiu-Fen Xu; Hao-Yan Wang; Richard Casaburi
Journal:  BMC Pulm Med       Date:  2014-02-07       Impact factor: 3.317

6.  Importance of slow vital capacity in the detection of airway obstruction.

Authors:  Ana Raquel Gonçalves de Barros; Margarida Batista Pires; Nuno Miguel Ferreira Raposo
Journal:  J Bras Pneumol       Date:  2013 May-Jun       Impact factor: 2.624

7.  Prognostic Value of the Six-Second Spirometry in Patients with Chronic Obstructive Pulmonary Disease: A Cohort Study.

Authors:  Eva Prats; Elena Tejero; Paloma Pardo; Adelaida Gavilán; Raúl Galera; José Ramón Donado; Miguel Ángel Racionero; Raquel Casitas; Antonio Zapatero; Francisco García-Río
Journal:  PLoS One       Date:  2015-10-21       Impact factor: 3.240

Review 8.  The physiological basis and clinical significance of lung volume measurements.

Authors:  Mohamed Faisal Lutfi
Journal:  Multidiscip Respir Med       Date:  2017-02-09

9.  Comparison of the prevalence of chronic obstructive pulmonary disease diagnosed by lower limit of normal and fixed ratio criteria.

Authors:  Yong Il Hwang; Chang Hwan Kim; Hye-Ryun Kang; Taerim Shin; Sang Myeon Park; Seung Hun Jang; Yong Bum Park; Cheol Hong Kim; Dong-Gyu Kim; Myung Goo Lee; In-Gyu Hyun; Ki-Suck Jung
Journal:  J Korean Med Sci       Date:  2009-07-29       Impact factor: 2.153

10.  COPD diagnosis related to different guidelines and spirometry techniques.

Authors:  Lennart Nathell; Madelene Nathell; Per Malmberg; Kjell Larsson
Journal:  Respir Res       Date:  2007-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.